These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7911611)

  • 1. Dipeptidyl peptidase IV: development, design, synthesis and biological evaluation of inhibitors.
    Borloo M; De Meester I
    Verh K Acad Geneeskd Belg; 1994; 56(1):57-88. PubMed ID: 7911611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII.
    Leiting B; Pryor KD; Wu JK; Marsilio F; Patel RA; Craik CS; Ellman JA; Cummings RT; Thornberry NA
    Biochem J; 2003 Apr; 371(Pt 2):525-32. PubMed ID: 12529175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific and irreversible cyclopeptide inhibitors of dipeptidyl peptidase IV activity of the T-cell activation antigen CD26.
    Nguyen C; Blanco J; Mazaleyrat JP; Krust B; Callebaut C; Jacotot E; Hovanessian AG; Wakselman M
    J Med Chem; 1998 Jun; 41(12):2100-10. PubMed ID: 9622551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DPP IV inhibitor blocks mescaline-induced scratching and amphetamine-induced hyperactivity in mice.
    Lautar SL; Rojas C; Slusher BS; Wozniak KM; Wu Y; Thomas AG; Waldon D; Li W; Ferraris D; Belyakov S
    Brain Res; 2005 Jun; 1048(1-2):177-84. PubMed ID: 15925329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoro-olefins as peptidomimetic inhibitors of dipeptidyl peptidases.
    Van der Veken P; Senten K; Kertèsz I; De Meester I; Lambeir AM; Maes MB; Scharpé S; Haemers A; Augustyns K
    J Med Chem; 2005 Mar; 48(6):1768-80. PubMed ID: 15771423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid parallel synthesis of dipeptide diphenyl phosphonate esters as inhibitors of dipeptidyl peptidases.
    Senten K; Daniëls L; Van der Veken P; De Meester I; Lambeir AM; Scharpé S; Haemers A; Augustyns K
    J Comb Chem; 2003; 5(3):336-44. PubMed ID: 12739951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human U937 cell surface peptidase activities: characterization and degradative effect on tumor necrosis factor-alpha.
    Bauvois B; Sancéau J; Wietzerbin J
    Eur J Immunol; 1992 Apr; 22(4):923-30. PubMed ID: 1348032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structural comparison of the bacterial PepX and human DPP-IV reveals sites for the design of inhibitors of PepX activity.
    Rigolet P; Xi XG; Rety S; Chich JF
    FEBS J; 2005 Apr; 272(8):2050-9. PubMed ID: 15819895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipeptide boronic acid inhibitors of dipeptidyl peptidase IV: determinants of potency and in vivo efficacy and safety.
    Connolly BA; Sanford DG; Chiluwal AK; Healey SE; Peters DE; Dimare MT; Wu W; Liu Y; Maw H; Zhou Y; Li Y; Jin Z; Sudmeier JL; Lai JH; Bachovchin WW
    J Med Chem; 2008 Oct; 51(19):6005-13. PubMed ID: 18783201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptide proline diphenyl phosphonates are potent, irreversible inhibitors of seprase (FAPalpha).
    Gilmore BF; Lynas JF; Scott CJ; McGoohan C; Martin L; Walker B
    Biochem Biophys Res Commun; 2006 Jul; 346(2):436-46. PubMed ID: 16769036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors.
    Belyaev A; Zhang X; Augustyns K; Lambeir AM; De Meester I; Vedernikova I; Scharpé S; Haemers A
    J Med Chem; 1999 Mar; 42(6):1041-52. PubMed ID: 10090787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and discovery of a novel dipeptidyl-peptidase IV (CD26)-based prodrug approach.
    García-Aparicio C; Bonache MC; De Meester I; San-Félix A; Balzarini J; Camarasa MJ; Velazquez S
    J Med Chem; 2006 Aug; 49(17):5339-51. PubMed ID: 16913724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine.
    Ludwig A; Schiemann F; Mentlein R; Lindner B; Brandt E
    J Leukoc Biol; 2002 Jul; 72(1):183-91. PubMed ID: 12101279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoacylpyrrolidine-2-nitriles: potent and stable inhibitors of dipeptidyl-peptidase IV (CD 26).
    Li J; Wilk E; Wilk S
    Arch Biochem Biophys; 1995 Oct; 323(1):148-54. PubMed ID: 7487060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition.
    Kirby M; Yu DM; O'Connor S; Gorrell MD
    Clin Sci (Lond); 2009 Sep; 118(1):31-41. PubMed ID: 19780719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, kinetic evaluation, and utilization of a biotinylated dipeptide proline diphenyl phosphonate for the disclosure of dipeptidyl peptidase IV-like serine proteases.
    Gilmore BF; Carson L; McShane LL; Quinn D; Coulter WA; Walker B
    Biochem Biophys Res Commun; 2006 Aug; 347(1):373-9. PubMed ID: 16824486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitors.
    Longenecker KL; Stewart KD; Madar DJ; Jakob CG; Fry EH; Wilk S; Lin CW; Ballaron SJ; Stashko MA; Lubben TH; Yong H; Pireh D; Pei Z; Basha F; Wiedeman PE; von Geldern TW; Trevillyan JM; Stoll VS
    Biochemistry; 2006 Jun; 45(24):7474-82. PubMed ID: 16768443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and SAR of potent and selective dipeptide-derived inhibitors for dipeptidyl peptidases.
    Senten K; Van der Veken P; De Meester I; Lambeir AM; Scharpé S; Haemers A; Augustyns K
    J Med Chem; 2003 Nov; 46(23):5005-14. PubMed ID: 14584950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamic acid analogues as potent dipeptidyl peptidase IV and 8 inhibitors.
    Lu IL; Lee SJ; Tsu H; Wu SY; Kao KH; Chien CH; Chang YY; Chen YS; Cheng JH; Chang CN; Chen TW; Chang SP; Chen X; Jiaang WT
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3271-5. PubMed ID: 15927466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-Substituted boro-proline dipeptides: synthesis, characterization, and dipeptidyl peptidase IV, 8, and 9 activities.
    Wu W; Liu Y; Milo LJ; Shu Y; Zhao P; Li Y; Woznica I; Yu G; Sanford DG; Zhou Y; Poplawski SE; Connolly BA; Sudmeier JL; Bachovchin WW; Lai JH
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5536-40. PubMed ID: 22853995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.